An EBV-Positive Lymphoproliferative Disorder after Therapy with Alemtuzumab [6] (multiple letters)

Irene M. Ghobrial, Larry A. Otteman, William L. White, David A. Rizzieri, Steve Weitman, Dana M. Vaughn

Research output: Contribution to journalLetterpeer-review

26 Scopus citations
Original languageEnglish (US)
Pages (from-to)2570-2572
Number of pages3
JournalNew England Journal of Medicine
Volume349
Issue number26
DOIs
StatePublished - Dec 25 2003
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this